Indogulf Cropsciences Ltd is Rated Sell

1 hour ago
share
Share Via
Indogulf Cropsciences Ltd is rated Sell by MarketsMojo, with this rating last updated on 20 April 2026. However, the analysis and financial metrics discussed here reflect the stock’s current position as of 26 June 2026, providing investors with the most recent and relevant data to assess the company’s outlook.
Indogulf Cropsciences Ltd is Rated Sell

Current Rating Overview

MarketsMOJO’s current rating of Sell for Indogulf Cropsciences Ltd is based on a comprehensive evaluation of four key parameters: Quality, Valuation, Financial Trend, and Technicals. The company’s Mojo Score stands at 45.0, reflecting a cautious stance for investors. This score represents a decline of 7 points from the previous rating of Hold, which was in place before 20 April 2026.

Quality Assessment

As of 26 June 2026, Indogulf Cropsciences exhibits an average quality grade. The company’s ability to generate returns on shareholder equity remains modest, with an average Return on Equity (ROE) of 13.49%. While this indicates some profitability, it is relatively low compared to industry benchmarks, signalling limited efficiency in deploying shareholders’ funds. Additionally, the company’s debt servicing capacity is a concern, with a high Debt to EBITDA ratio of 3.16 times. This elevated leverage suggests increased financial risk, as the company may face challenges in meeting its debt obligations comfortably.

Valuation Perspective

From a valuation standpoint, Indogulf Cropsciences is currently very attractively priced. This suggests that the stock trades at a discount relative to its intrinsic value or sector peers, potentially offering value to investors who are willing to accept the associated risks. However, attractive valuation alone does not offset the concerns raised by other parameters, particularly the company’s financial trend and technical outlook.

Financial Trend Analysis

The financial trend for Indogulf Cropsciences is largely flat, indicating stagnation in key performance metrics. Over the past five years, the company’s net sales have grown at a modest annual rate of 7.30%, while operating profit has increased by 9.70% annually. These growth rates are relatively subdued, especially in the context of the broader fertilizers sector, which often benefits from cyclical demand and agricultural trends. Furthermore, the latest quarterly results ending March 2026 reveal a decline in net sales by 11.3% to ₹150.82 crores compared to the previous four-quarter average, signalling potential headwinds in the near term.

Technical Outlook

Technically, the stock is mildly bearish as of 26 June 2026. Recent price movements show a downward trend, with the stock declining 2.84% in a single day and 5.48% over the past week. The one-month performance also reflects a 4.78% drop, although the three-month return shows a positive 10.24%, indicating some short-term recovery. Despite this, the six-month and year-to-date returns remain deeply negative at -28.58% and -28.24% respectively, underscoring persistent selling pressure and weak investor sentiment.

Implications for Investors

The Sell rating implies that investors should exercise caution with Indogulf Cropsciences Ltd at present. While the stock’s valuation appears attractive, the combination of average quality, flat financial trends, and bearish technical signals suggests limited upside potential and elevated risk. Investors may want to consider these factors carefully before initiating or maintaining positions in the stock, particularly given the company’s high leverage and recent sales decline.

Sector and Market Context

Operating within the fertilizers sector, Indogulf Cropsciences faces competitive pressures and cyclical demand patterns that influence its performance. The microcap status of the company also adds an element of liquidity risk, which can amplify price volatility. Compared to broader market indices and sector peers, the company’s subdued growth and financial constraints highlight the challenges it currently faces.

Momentum just kicked in! This Small Cap from the Auto - Trucks sector entered our list with explosive short-term signals. Catch the wave while it's still building!

  • - Fresh momentum detected
  • - Explosive short-term signals
  • - Early wave positioning

Catch the Wave Now →

Summary of Key Metrics as of 26 June 2026

To summarise, the stock’s recent performance metrics are as follows: a one-day decline of 2.84%, a one-week drop of 5.48%, and a one-month decrease of 4.78%. The three-month return is a positive 10.24%, but this is overshadowed by a six-month loss of 28.58% and a year-to-date decline of 28.24%. The company’s financial health is marked by a high Debt to EBITDA ratio of 3.16 times and a modest ROE of 13.49%. Net sales have shown a slight contraction in the latest quarter, falling 11.3% to ₹150.82 crores.

What This Means for Portfolio Strategy

Investors seeking exposure to the fertilizers sector might find Indogulf Cropsciences’ current valuation tempting. However, the overall assessment suggests that the stock carries significant risks due to its financial leverage, flat growth trajectory, and bearish technical indicators. A Sell rating advises a cautious approach, recommending that investors either reduce exposure or avoid new positions until there is clearer evidence of financial improvement and technical strength.

Looking Ahead

Going forward, monitoring the company’s ability to improve its debt servicing capacity and return to consistent sales growth will be critical. Any positive developments in these areas could alter the stock’s outlook. Until then, the current Sell rating reflects a prudent stance based on the comprehensive analysis of the company’s fundamentals and market behaviour as of 26 June 2026.

Conclusion

Indogulf Cropsciences Ltd’s current Sell rating by MarketsMOJO is grounded in a balanced evaluation of quality, valuation, financial trends, and technical factors. While the stock is attractively valued, the risks associated with leverage, flat growth, and recent sales decline outweigh the potential benefits. Investors should carefully weigh these factors in their decision-making process and remain vigilant for any changes in the company’s financial health or market dynamics.

{{stockdata.stock.stock_name.value}} Live

{{stockdata.stock.price.value}} {{stockdata.stock.price_difference.value}} ({{stockdata.stock.price_percentage.value}}%)

{{stockdata.stock.date.value}} | BSE+NSE Vol: {{stockdata.index_name}} Vol: {{stockdata.stock.bse_nse_vol.value}} ({{stockdata.stock.bse_nse_vol_per.value}}%)


Our weekly and monthly stock recommendations are here
Loading...
{{!sm.blur ? sm.comp_name : ''}}
Industry
{{sm.old_ind_name }}
Market Cap
{{sm.mcapsizerank }}
Date of Entry
{{sm.date }}
Entry Price
Target Price
{{sm.target_price }} ({{sm.performance_target }}%)
Holding Duration
{{sm.target_duration }}
Last 1 Year Return
{{sm.performance_1y}}%
{{sm.comp_name}} price as on {{sm.todays_date}}
{{sm.price_as_on}} ({{sm.performance}}%)
Industry
{{sm.old_ind_name}}
Market Cap
{{sm.mcapsizerank}}
Date of Entry
{{sm.date}}
Entry Price
{{sm.opening_price}}
Last 1 Year Return
{{sm.performance_1y}}%
Related News